Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2016-10-14

FDA Approved: IRBESARTAN AND HYDROCHLOROTHIAZIDE — Original Application (Hisun Pharmaceuticals USA Inc.)

View source ↗

Summary

FDA approved a generic fixed-dose combination tablet of irbesartan and hydrochlorothiazide from Hisun Pharmaceuticals USA Inc. for hypertension.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • IRBESARTAN AND HYDROCHLOROTHIAZIDE (irbesartan and hydrochlorothiazide)

Snippet

ORIG AP for IRBESARTAN AND HYDROCHLOROTHIAZIDE (IRBESARTAN AND HYDROCHLOROTHIAZIDE)